Jump to content


Photo

Typical Healthcare Costs Living with CML


  • Please log in to reply
16 replies to this topic

#1 CDW

CDW

    New Member

  • Members
  • Pip
  • 4 posts

Posted 06 January 2018 - 08:48 AM

Hello All,

 

I would be grateful if you would share some typical healthcare costs you incur while living with CML. I am planning to move back to the USA for family reasons and need to calculate typical healthcare outgoings. I've been in MMR for 7 years and am on Tasigna with no other complications. I know this is entirely variable based on the quality of your plan, but I'm after some general costs to gauge the level of outgoing.

 

- How much do you pay for monthly coverage and how much are co-pays to get your TKIs?

- What's your total annual outlay on healthcare out of pocket costs?

 

I am still of working age and I know the Medicaid donut hole is a problem, so I'd prefer not to go down that rabbit hole.

 

Grateful for any info you're willing to share.

 

Thanks

 

Chris  



#2 tiredblood

tiredblood

    Advanced Member

  • Members
  • PipPipPip
  • 474 posts

Posted 06 January 2018 - 12:54 PM

~$106 biweekly my contribution to healthcare coverage. I don't have the amount of my employer's contribution to my health plan with me right now. $95/90-day supply of Tasigna (I think that was 2016). $155 for 90-day supply of Gleevec. I think it is $55 for a 30-day supply which is required for first three fills when you're new to the drug— then can get 90-day after that.

#3 Antilogical

Antilogical

    Advanced Member

  • Members
  • PipPipPip
  • 284 posts
  • LocationPittsburgh, PA

Posted 06 January 2018 - 01:37 PM

If you're planning to work, it will depend on whatever healthcare insurance plans your employer offers.  I'm on Medicare now, but when I was working, I paid $25 per month for my TKI drug.  It didn't matter which drug it was -- any drug in the tier 5 category was $25.  Right before I retired, they modified the benefits, so the monthly cost for tier 5 drugs went up to $200.  However, I was able to get a copay card from Novartis that lowered my cost to $10. 

 

Those were the good old days.  If you're up for it, check out the "Cost of Generic Imatinib just got higher!" thread to see the current copays on Medicare.  http://community.lls...ust-got-higher/


Dx: Sudden severe anemia detected 07/2011, followed by WBC spike. CML Dx 02/2012.

Rx: 03/2012-Gleevec400.  Reduced 02/2013 to Gleevec300 due to side effects (low blood counts).

Response: PCR-Und within 7 mo. on G400. Maintained MMR4-MMR4.5 on G300. PCR-Und since 02/2016.


#4 tiredblood

tiredblood

    Advanced Member

  • Members
  • PipPipPip
  • 474 posts

Posted 06 January 2018 - 03:48 PM

Like antilogical said, it does depend on the plan. I had one job that my initial copay for Tasigna was going to be $3000. Then, the next copays were going to be much less. There was a health savings account as part of the package. I just left and went back to my old job where the copay was the same all the time , instead of a big copay up front.

#5 CDW

CDW

    New Member

  • Members
  • Pip
  • 4 posts

Posted 06 January 2018 - 04:01 PM

Hi, thanks for the replies so far, really useful. I am planning to work, got a couple of decades of work in front of me before I can retire ;-) 

 

I've been researching the Novartis co-pay card and it was useful to hear someone using it with success. I'm moving back to no job, so will have to buy insurance off an exchange - the plans I've seen have OK coverage, but the Tasigna requires a 30% co-pay, with a maximum out of pocket cost capped at ~$12,000. I am seriously hopeful that I'll be able to use a Novartis co-pay card until I get better insurance with a job. 

 

C



#6 cmljax

cmljax

    Advanced Member

  • Members
  • PipPipPip
  • 115 posts

Posted 06 January 2018 - 04:26 PM

The Novartis co-pay card does work, but you have to have commercial health insurance to use it. It reimburses up to $15,000 per year of your copays.  I am currently on UnitedHealthcare and got a letter about 2 months ago that said they knew I was using the Novartis co-pay program and starting in 2018 they would adjust my deductible and out of pocket categories $ for $ for any reimbursement I receive from Novartis.  Guess they have a way to track this.  Do not know if other health insurance companies have figured this out yet or not.  You have nothing to lose to try it and see. 

 

I start on Medicare on 4/1/2018, so no copay program is allowed anyway.  I know my out of pocket costs for Tasigna will go up due to donut hole and copays even in catastrophic for specialty drugs.  I am blessed that I can afford it and even more blessed that I am only on 150 mg per day right now which is a retail about $3000 per month versus $12,000 when I was on 600 mg.

 

Good luck and glad you're doing so well on Tasigna.  It beat the crap out of me for the first 9 months or so, but much better on low dose. 


Dx 9/26/16 WBC 28800; platelets 749; FISH 97% PCR 43%

Tasigna 600MG per day

October 2016                     PCR 22% IS

November 2016                 PCR 5.8% IS

December 2016                 PCR 0.1% IS  MMR!!

March 10, 2017                 PCR 0.006% IS  MR 4.22

Tasigna 450MG per day

April 5, 2017                      PCR <.003% IS

June 5, 2017                     PCR <.003% IS (dose reduction validated!!!)

Tasigna 300MG per day starting June 15, 2017

6-day drug break starting June 20, 2017 due to multiple AE's

July 24, 2017                     PCR <.003% IS

September 18, 2017          Negative, AKA PCRU

Tasigna 150mg per day starting 9/18/17

October 30, 2017               Negative

December 11, 2017           Negative


#7 chriskuo

chriskuo

    Advanced Member

  • Members
  • PipPipPip
  • 367 posts

Posted 08 January 2018 - 12:56 AM

To clarify, the donut hole is not a Medicaid issue, it is a Medicare issue.

 

Insurance costs in the exchanges vary widely depending on the state.  Do you know which state you are moving to and do you have a choice?



#8 CDW

CDW

    New Member

  • Members
  • Pip
  • 4 posts

Posted 09 January 2018 - 03:44 PM

Hi, I'm moving to Ohio and will initially be buying off the exchange. From what I've seen, the insurers do cover Tasigna but have a hefty co-pay (30%) and i'll end up hitting the max out of pocket of ~$12k each year. Obviously, the Novartis co-pay card would help reduce the out of pocket cost.

 

I therefore (I think) have an idea of how much the monthly payment will be until such a time as i get a job with reasonable insurance. It's useful to see how much people are typically paying and what I could expect to pay once I secure decent employment.

 

Thanks for the responses.

 

Chris



#9 beno

beno

    Advanced Member

  • Members
  • PipPipPip
  • 92 posts
  • LocationIowa

Posted 10 January 2018 - 12:43 PM

My copay with BCBS is $85 monthly.  I pay about $200 quarterly for doctor visit/PCR tests.


DX 3/30/2016 WBC 484.2 FISH 95.3

took Hydrea 3/30-4/11

taking Sprycel 100 mg since 4/5

10 day break from Sprycel for platelet count of 12 4/26-5/8

7/07/2016 1.47% (IS)

9/30/16 BMB PCR .1259 switched to new onc

12/30/16 PCR .1569

4/7/17 PCR .0904 MMR

7/14/17 PCR .0520

12/1/17 PCR .0148


#10 IGotCML

IGotCML

    Advanced Member

  • Members
  • PipPipPip
  • 57 posts
  • LocationDallas / Fort Worth, TX

Posted 12 January 2018 - 11:55 PM

My monthly copay for Tasigna with my employer's health insurance is $100 once I hit my copay which occurs in the first month of the plan. My annual out of pocket cost for CML treatment (including my health insurance premiums) is around $5,000 per year.



#11 chriskuo

chriskuo

    Advanced Member

  • Members
  • PipPipPip
  • 367 posts

Posted 13 January 2018 - 02:19 AM

Employer insurance for prescriptions is almost always better than Medicare Part D (even with employer subsidies for retirees) and given lack of copay assistance for middle-class seniors.  There is charitable help available for seniors with serious financial limitations.



#12 CDW

CDW

    New Member

  • Members
  • Pip
  • 4 posts

Posted 14 January 2018 - 10:18 AM

thanks everyone for your replies. It's such shame the generic imatinib has not been the cost game-changer we hoped for. The Medicare donut hole is also a disgrace really. Currently in the UK, the National Health Service pays ~$40,000 per year for Tasigna/Imatinib and this was achieved through negotiation with Novartis. There is no reason the US Government shouldn't lobby Novartis for similar discount for the Medicare program.

 

Thanks again

 

Chris



#13 chriskuo

chriskuo

    Advanced Member

  • Members
  • PipPipPip
  • 367 posts

Posted 15 January 2018 - 03:45 AM

CDW,

 

There is a reason that the US government can't negotiate drug prices for Medicare.

It is against the policy and philosophy of the ruling party in the United States.

There may be reasons why the ruling party could be overthrown in the future, but Medicare drug prices are not high on the list.

Remember that a minority of voters are on Medicare and of those on Medicare, fewer than 30% even enter the donut hole and maybe 5% get into the catastrophic phase.  Under current law, the donut hole is shrinking over the next few years, but politics could intervene for better or worse in the next few years.



#14 hannibellemo

hannibellemo

    Advanced Member

  • Members
  • PipPipPip
  • 728 posts
  • LocationNorth Central Iowa

Posted 15 January 2018 - 02:59 PM

I'm on Medicare now but when I was working I paid nothing for my health insurance for the first several years and by the time I retired I was paying about $125/mo. My out of pocket was $1,000 and that is all I paid for the entire year for medicines and doctor visits. We did not have a separate drug plan, everything was covered under major medical.

 

I really miss that insurance!!  :D


Pat

 

"You can't change the direction of the wind but you can adjust your sails."

DX 12/08; Gleevec 400mg; liver toxicity; Sprycel 100mg.; CCyR 4/10; MMR 8/10; Pleural Effusion 2/12; Sprycel 50mg. Maintaining MMR; 2/15 PCRU; 8/16 drifting in and out of undetected like a wave meeting the shore. Retired 12/23/2016! 18 months of PCRU, most recent at Mayo on 7/25/17 was negative at their new sensitivity reporting of 0.003.<p>


#15 Susan61

Susan61

    Advanced Member

  • Members
  • PipPipPip
  • 43 posts
  • LocationNew Jersey

Posted 20 January 2018 - 05:28 PM

I do not know who remembers me.  Have had trouble getting back on for awhile, and hope I do not lose you again.  I have been on Gleevec since Oct. of 2000, and have been PCRU since 2001.  I am still on 400mg a day, and we have lost our insurance since my  husband is very sick and lost his job.  I am now on Medicare with Secondary.  I am trying to get help from Novartis, as I did the clinical trial for Gleevec.  I was promised that I would get it for free if we ever could not afford it or lose insurance.  I will be starting the process of all the forms etc.

No idea what I will do if I cannot get help.  Any input is appreciated with this.

I am at 0.000 on PCR Test.  Waiting for my most recent PCR results this week.



#16 Melanie

Melanie

    Advanced Member

  • Members
  • PipPipPip
  • 219 posts
  • LocationArizona

Posted 20 January 2018 - 09:22 PM

Susan, I remember you! You were a big comfort to me back in the beginning of my journey in 2011. So sorry about your husband being sick! After so long PCRU, I would think you're a perfect candidate for cessation. Have you talked to your Drs about it?

Regardless, I sure hope you get some help from Novartis. You're one of the original pioneers. Praying for you and your husband. Take care!
Dx - 05/2011; PCR: 15.04; Fish: 87% Slow responder due to pancytopenia. Current - Bosulif - Nov: 2012, Mar 2016 lowered to 300 mg. 07/16 back to 400 mg. Clinical trial drug, Promacta, Feb 2013, for low Platelets.
CyCR - Aug 2014, Positive for 1 chromosome Sep 2015. PCR: 12.77 in Oct, 2012 to 0.04 (MDA) in Mar, 2016. 4/2016 - 0.126 (Local lab (IS); 05/2016 - 0.195 (local); 6/2016 - 0.07 (MDA); 7/2016 - 0.03 (local) 9/13/2016 - 0.16 (MDA); 9/26/2016 - 0.31 (MDA); 11/2016 - 0.012 (local); 01/2017 - 0.24 (MDA); 04/2017 - 0.09 (MDA); Cytogenetics show der(1:7)(q10;p10)7 chromosome mutation. Repeat of Sep 2015. PCR - 6/2017- 0.035 (local); 10/2017- 0.02 (MDA)

#17 kat73

kat73

    Advanced Member

  • Members
  • PipPipPip
  • 884 posts
  • LocationWashington, DC area

Posted 22 January 2018 - 10:30 AM

Yay, Susan, you're back!  I've been wondering where you were and hoping you hadn't gone to the other LLS space or were in physical trouble.  Missed you and your counsels, your voice!

 

I am so sorry about your husband - I remember he had many troubles.  I wish him the best. 

 

I am sure the powers that be are going to honor their pledge to you as a Gleevec pioneer.  It would certainly be in their interest to keep track of such a long-term patient on Gleevec.  You should certainly persevere in that.

 

I remember how reluctant you have always been to go the cessation route.  People tend to forget that there is no guarantee for success just because of many years of PCRU - look at Trey's experience.  You do what's right for you.  But, it might be an option to consider now.


Dx July 2009 on routine physical.  WBC 94.  Started Gleevec 400 mg Sept 2009.  MMR at 2yrs.  Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved.  Kidney issues developed because of Gleevec.  Switched to Sprycel 70 mg in Aug 2011.  Above side effects disappeared or improved.  Have been MR3.5 - 4.5 ever since.  Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017.  After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS.  Pleural effusion returned within a couple of months, same as before (moderate, left side only).  Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved.  At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.





1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users